To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Intravenous & Periarticular Corticosteroid for Pain Relief After Total Knee Arthroplasty

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
July 2023

Intravenous & Periarticular Corticosteroid for Pain Relief After Total Knee Arthroplasty

Vol: 303| Issue: 7| Number:26| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Pain Relief After Total Knee Arthroplasty with Intravenous and Periarticular Corticosteroid: A Randomized Controlled Trial.

J Bone Joint Surg Am. 2023 Jun 21;105(12): 924-932.

Contributing Authors:
PK Chan TCW Chan CYH Mak THM Chan SHW Chan SSC Wong H Fu A Cheung VWK Chan MH Cheung CW Cheung KY Chiu

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

180 patients scheduled to undergo a total knee arthroplasty were randomized to receive corticosteroid applied intravenously (n=45), peri-articularly (n=45), or both (n=45), or a placebo treatment (n=45). The primary outcome of interest was post-operative pain as measured on a Numeric Rating Scale (NRS). Functional outcomes, mobility scores, morphine consumption, quality of recovery and discharge d...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue